Matrilysin-1 (MMP-7) and MMP-19 are expressed by Paget's cells in extramammary Paget's disease.

about

Ber-EP4 enhances the differential diagnostic accuracy of cytokeratin 7 in pagetoid cutaneous neoplasms.

P2860

Q42525659-CC86506D-C763-4A9F-BD53-4535ECF77199

P2860

Matrilysin-1 (MMP-7) and MMP-19 are expressed by Paget's cells in extramammary Paget's disease.

Item

http://www.wikidata.org/entity/Q47235743

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Matrilysin-1 (MMP-7) and MMP-1 ...... extramammary Paget's disease.

@en

Matrilysin-1

@nl

type

Item

label

Matrilysin-1 (MMP-7) and MMP-1 ...... extramammary Paget's disease.

@en

Matrilysin-1

@nl

prefLabel

Matrilysin-1 (MMP-7) and MMP-1 ...... extramammary Paget's disease.

@en

Matrilysin-1

@nl

P1476

Matrilysin-1 (MMP-7) and MMP-1 ...... n extramammary Paget's disease

@en

P2093

Maarit Tanskanen

http://www.w3.org/2001/XMLSchema#string

Sirpa Asko-Seljavaara

http://www.w3.org/2001/XMLSchema#string

Tiina Jahkola

http://www.w3.org/2001/XMLSchema#string

Tiina Kuivanen

http://www.w3.org/2001/XMLSchema#string

Ulpu Saarialho-Kere

http://www.w3.org/2001/XMLSchema#string

P2860

Biochemical characterization of the catalytic domain of human matrix metalloproteinase 19. Evidence for a role as a potent basement membrane degrading enzyme

Identification and characterization of a novel human matrix metalloproteinase with unique structural characteristics, chromosomal location, and tissue distribution

Matrix metalloproteinases 19 and 20 cleave aggrecan and cartilage oligomeric matrix protein (COMP)

Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5

Matrix metalloproteinase MMP-19 (RASI-1) is expressed on the surface of activated peripheral blood mononuclear cells and is detected as an autoantigen in rheumatoid arthritis

Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis

Photodynamic therapy for the treatment of extramammary Paget's disease.

Prognosis and management of extramammary Paget's disease and the association with secondary malignancies.

Matrix metalloproteinases: they're not just for matrix anymore!

Laminin-5 in the progression of carcinomas.

P304

483-491

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.0303-6987.2004.00211.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ulla Impola

P577

2004-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8468846

http://www.w3.org/2001/XMLSchema#string

P698

15239678

http://www.w3.org/2001/XMLSchema#string

Matrilysin-1 (MMP-7) and MMP-19 are expressed by Paget's cells in extramammary Paget's disease.

about

P2860

P2860

Matrilysin-1 (MMP-7) and MMP-19 are expressed by Paget's cells in extramammary Paget's disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698